First Header Logo Second Header Logo

Thomas Wierzba

Concepts (288)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholera Vaccines
19
2019
19
5.110
Why?
Typhoid Fever
17
2019
19
4.840
Why?
Cholera
21
2019
21
4.560
Why?
Diarrhea
19
2019
56
4.050
Why?
Escherichia coli Infections
14
2019
37
3.500
Why?
Escherichia coli Vaccines
8
2019
10
2.670
Why?
Dysentery, Bacillary
8
2019
12
2.290
Why?
Enterotoxigenic Escherichia coli
8
2019
15
2.030
Why?
Shigella Vaccines
5
2019
5
1.950
Why?
Child, Preschool
45
2019
1185
1.910
Why?
Vaccination
10
2016
114
1.820
Why?
Infant
41
2019
972
1.810
Why?
Child
45
2019
2220
1.750
Why?
Hepatitis E
4
2018
6
1.750
Why?
Salmonella Infections
9
2018
11
1.730
Why?
Developing Countries
8
2019
42
1.600
Why?
Disease Outbreaks
7
2018
35
1.520
Why?
Adolescent
42
2019
3298
1.520
Why?
Antibodies, Bacterial
6
2019
30
1.400
Why?
Mass Vaccination
5
2016
7
1.360
Why?
Influenza, Human
7
2014
120
1.260
Why?
Humans
88
2019
29541
1.220
Why?
Models, Theoretical
3
2018
127
1.140
Why?
Typhoid-Paratyphoid Vaccines
5
2019
6
1.130
Why?
Shigella
5
2019
7
1.060
Why?
Immunity, Herd
4
2019
5
1.060
Why?
Fever
7
2018
58
1.000
Why?
Young Adult
28
2019
2456
0.970
Why?
India
13
2018
62
0.960
Why?
Administration, Oral
14
2019
172
0.940
Why?
Population Surveillance
8
2014
118
0.890
Why?
Bacterial Vaccines
2
2012
7
0.860
Why?
Female
49
2019
18476
0.840
Why?
Paratyphoid Fever
2
2019
3
0.830
Why?
Salmonella
3
2018
3
0.810
Why?
Vibrio cholerae
3
2015
3
0.810
Why?
Adult
34
2019
8698
0.800
Why?
Viral Vaccines
2
2011
13
0.750
Why?
Escherichia coli
5
2014
81
0.750
Why?
Salmonella typhi
9
2018
10
0.750
Why?
Male
46
2019
18199
0.740
Why?
Incidence
12
2018
1103
0.720
Why?
Vaccines, Conjugate
4
2019
15
0.690
Why?
Sanitation
1
2018
3
0.680
Why?
Hygiene
1
2018
13
0.680
Why?
Rotavirus Infections
4
2019
11
0.670
Why?
Mortality
2
2019
109
0.630
Why?
Enteritis
2
2019
5
0.600
Why?
Encephalitis, Japanese
3
2015
3
0.590
Why?
Immunization, Secondary
2
2016
10
0.590
Why?
Severity of Illness Index
3
2016
868
0.580
Why?
Rural Population
8
2016
242
0.580
Why?
Environmental Monitoring
2
2013
26
0.560
Why?
Vaccines, Inactivated
9
2018
36
0.550
Why?
Reagent Kits, Diagnostic
2
2012
11
0.540
Why?
Water Supply
1
2014
10
0.520
Why?
Enteropathogenic Escherichia coli
1
2014
3
0.520
Why?
Influenza A Virus, H1N1 Subtype
2
2012
48
0.520
Why?
Diarrhea, Infantile
1
2014
6
0.520
Why?
Intestinal Perforation
1
2014
9
0.510
Why?
Anti-Bacterial Agents
8
2016
291
0.480
Why?
Salmonella enterica
4
2016
5
0.470
Why?
Cause of Death
1
2014
223
0.470
Why?
Length of Stay
1
2014
285
0.460
Why?
Egypt
12
2014
16
0.440
Why?
Neisseria meningitidis, Serogroup A
1
2012
1
0.440
Why?
Clinical Trials as Topic
5
2019
303
0.430
Why?
Residence Characteristics
2
2016
166
0.420
Why?
Point-of-Care Systems
1
2012
33
0.420
Why?
Africa South of the Sahara
8
2018
20
0.420
Why?
Infant, Newborn
14
2019
595
0.400
Why?
Feces
6
2019
29
0.390
Why?
Double-Blind Method
7
2018
506
0.390
Why?
Cambodia
8
2014
8
0.380
Why?
Bacteremia
3
2016
52
0.380
Why?
Bacterial Infections
2
2012
41
0.380
Why?
Enzyme-Linked Immunosorbent Assay
5
2018
160
0.380
Why?
Campylobacter Infections
2
2008
6
0.370
Why?
Measles
1
2009
3
0.360
Why?
Immunization
2
2019
27
0.360
Why?
Guillain-Barre Syndrome
1
2008
9
0.350
Why?
Tanzania
9
2015
12
0.350
Why?
Congresses as Topic
2
2019
38
0.340
Why?
Malaria
4
2016
10
0.320
Why?
Urban Population
3
2017
79
0.310
Why?
Ciprofloxacin
3
2016
12
0.300
Why?
Cost of Illness
3
2018
59
0.300
Why?
Prevalence
6
2016
897
0.300
Why?
Family Characteristics
2
2017
32
0.290
Why?
Middle Aged
12
2018
11220
0.290
Why?
Risk Factors
5
2018
3572
0.270
Why?
Cohort Studies
8
2019
1724
0.260
Why?
Databases, Factual
2
2016
330
0.260
Why?
Antibodies, Viral
2
2016
53
0.250
Why?
Japanese Encephalitis Vaccines
2
2015
2
0.250
Why?
Socioeconomic Factors
2
2017
383
0.250
Why?
Bangladesh
6
2019
7
0.240
Why?
Drug Resistance, Bacterial
3
2016
38
0.240
Why?
Drug Resistance, Multiple, Bacterial
2
2016
15
0.240
Why?
Patient Acceptance of Health Care
2
2016
155
0.230
Why?
Immunization Schedule
3
2019
24
0.210
Why?
Nepal
3
2014
9
0.210
Why?
Case-Control Studies
5
2015
914
0.190
Why?
Escherichia coli Proteins
3
2005
27
0.190
Why?
Rotavirus Vaccines
1
2019
7
0.180
Why?
Antigens, Bacterial
1
2019
18
0.180
Why?
Geographic Information Systems
1
2019
14
0.180
Why?
Cross-Sectional Studies
5
2016
1347
0.180
Why?
Sensitivity and Specificity
5
2012
545
0.180
Why?
Host-Pathogen Interactions
1
2019
30
0.180
Why?
Growth Disorders
1
2019
4
0.180
Why?
Cost-Benefit Analysis
1
2019
156
0.170
Why?
Pregnant Women
1
2018
6
0.170
Why?
Hepatitis Antibodies
1
2018
1
0.170
Why?
Jaundice
1
2018
5
0.170
Why?
Treatment Outcome
7
2015
3135
0.160
Why?
Macaca mulatta
1
2019
322
0.160
Why?
Disease Models, Animal
2
2019
1021
0.160
Why?
Gastrointestinal Diseases
1
2018
38
0.160
Why?
Seroepidemiologic Studies
2
2014
9
0.160
Why?
Africa
2
2014
24
0.160
Why?
Hepatitis E virus
2
2014
3
0.160
Why?
Drug Resistance, Multiple
1
2017
7
0.160
Why?
Pregnancy
3
2017
811
0.160
Why?
Vietnam
2
2014
23
0.160
Why?
Pregnancy Complications, Infectious
2
2014
27
0.150
Why?
Washington
1
2016
4
0.150
Why?
Milk, Human
1
2017
15
0.150
Why?
Microbial Sensitivity Tests
6
2016
56
0.150
Why?
Fatty Acids, Omega-6
1
2017
31
0.150
Why?
Geography
2
2014
30
0.150
Why?
Education
1
2016
30
0.150
Why?
Aged, 80 and over
5
2016
3750
0.150
Why?
Influenza A Virus, H9N2 Subtype
2
2014
3
0.150
Why?
Fatty Acids, Omega-3
1
2017
52
0.150
Why?
Endemic Diseases
1
2016
4
0.150
Why?
World Health Organization
2
2014
21
0.150
Why?
Uganda
1
2016
7
0.150
Why?
Indonesia
1
2016
7
0.150
Why?
Nigeria
1
2016
17
0.150
Why?
Enterotoxins
3
2005
6
0.150
Why?
Bacterial Toxins
3
2005
16
0.140
Why?
Immunity, Mucosal
1
2016
5
0.140
Why?
Poliovirus
1
2016
3
0.140
Why?
Antibody-Producing Cells
1
2016
3
0.140
Why?
Database Management Systems
1
2016
11
0.140
Why?
Public Health
2
2014
70
0.140
Why?
Hospitalization
2
2016
400
0.140
Why?
Aged
6
2016
9658
0.140
Why?
Salmonella paratyphi A
2
2013
2
0.140
Why?
Immunoglobulin A
4
2019
10
0.140
Why?
Research Design
2
2015
276
0.140
Why?
Haemophilus Vaccines
1
2015
1
0.140
Why?
Mice
2
2019
2401
0.140
Why?
Bacterial Capsules
1
2015
5
0.140
Why?
Haemophilus Infections
1
2015
7
0.140
Why?
B-Lymphocytes
1
2016
92
0.140
Why?
Longitudinal Studies
2
2016
709
0.130
Why?
Immunoglobulin G
4
2019
106
0.130
Why?
Health Expenditures
1
2015
59
0.130
Why?
Bacteriological Techniques
1
2014
15
0.130
Why?
Genotype
2
2014
826
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2011
261
0.130
Why?
Phenotype
2
2014
676
0.120
Why?
Animals
5
2019
7480
0.120
Why?
Bayes Theorem
1
2014
66
0.120
Why?
Salmonella Vaccines
1
2013
1
0.120
Why?
Internationality
1
2013
22
0.120
Why?
Population Density
1
2013
6
0.120
Why?
Educational Status
1
2014
162
0.120
Why?
Randomized Controlled Trials as Topic
1
2015
458
0.120
Why?
Republic of Korea
1
2012
8
0.110
Why?
Models, Statistical
1
2013
161
0.110
Why?
Computers, Handheld
1
2012
7
0.110
Why?
Niger
1
2012
1
0.110
Why?
Dengue
1
2012
4
0.110
Why?
Delivery of Health Care
1
2014
139
0.110
Why?
Community-Acquired Infections
1
2012
31
0.110
Why?
Influenza A Virus, H3N2 Subtype
1
2011
22
0.110
Why?
Sex Factors
1
2014
637
0.110
Why?
Reproducibility of Results
4
2016
716
0.110
Why?
Data Collection
1
2012
166
0.100
Why?
Vibrio cholerae O1
3
2015
3
0.100
Why?
Rotavirus
1
2010
4
0.100
Why?
Orthomyxoviridae
1
2010
14
0.100
Why?
Health Services Accessibility
1
2012
229
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2014
316
0.100
Why?
Fluoroquinolones
1
2009
10
0.090
Why?
Asia
3
2013
16
0.090
Why?
Gangliosides
1
2008
6
0.090
Why?
Indian Ocean Islands
3
2013
3
0.090
Why?
Cluster Analysis
3
2013
123
0.080
Why?
Prospective Studies
4
2017
2000
0.080
Why?
Azithromycin
2
2004
14
0.080
Why?
Retrospective Studies
3
2014
3156
0.080
Why?
Hospitals
3
2012
75
0.080
Why?
Survival Rate
1
2009
821
0.080
Why?
Vaccines, Subunit
2
2016
3
0.070
Why?
Ghana
2
2016
22
0.070
Why?
Seasons
1
2006
84
0.070
Why?
Cryptosporidiosis
1
2005
2
0.070
Why?
Cryptosporidium parvum
1
2005
2
0.070
Why?
Tuberculosis, Meningeal
1
2005
1
0.070
Why?
Tuberculoma, Intracranial
1
2005
1
0.070
Why?
Granuloma
1
2005
13
0.070
Why?
Interferon-gamma
1
2005
52
0.070
Why?
Interleukin-10
1
2005
31
0.070
Why?
Placebos
2
2015
62
0.070
Why?
Biomedical Research
2
2016
154
0.060
Why?
Campylobacter coli
1
2003
2
0.060
Why?
Campylobacter jejuni
1
2003
3
0.060
Why?
Probability
3
2012
150
0.060
Why?
Age Factors
2
2016
1111
0.060
Why?
Cholera Toxin
1
2002
5
0.060
Why?
Proportional Hazards Models
2
2015
727
0.050
Why?
Serotyping
2
2016
14
0.050
Why?
Adjuvants, Immunologic
1
2002
52
0.050
Why?
Bacteria
2
2012
45
0.050
Why?
Prognosis
3
2016
1451
0.050
Why?
Shigella sonnei
1
2019
1
0.050
Why?
Vaccines, Attenuated
1
2019
11
0.040
Why?
Dose-Response Relationship, Immunologic
1
2019
14
0.040
Why?
Quality-Adjusted Life Years
1
2019
23
0.040
Why?
Luminescent Measurements
1
2018
16
0.040
Why?
Electrochemical Techniques
1
2018
23
0.040
Why?
Age Distribution
2
2012
201
0.040
Why?
Vaccines, Combined
1
2017
4
0.040
Why?
Lactation
1
2017
14
0.040
Why?
Guinea-Bissau
1
2016
1
0.040
Why?
Senegal
1
2016
1
0.040
Why?
Molecular Epidemiology
1
2016
20
0.040
Why?
Clinical Audit
1
2016
1
0.040
Why?
Poliomyelitis
1
2016
2
0.040
Why?
Poliovirus Vaccine, Oral
1
2016
3
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2016
2
0.040
Why?
Antibodies, Neutralizing
1
2016
18
0.040
Why?
Weights and Measures
1
2015
3
0.040
Why?
Anthropometry
1
2016
83
0.040
Why?
Ethiopia
1
2015
1
0.030
Why?
Vibrio cholerae O139
1
2015
1
0.030
Why?
Outpatients
1
2015
51
0.030
Why?
Democratic People's Republic of Korea
1
2015
1
0.030
Why?
Inpatients
1
2015
54
0.030
Why?
Fimbriae Proteins
2
2005
5
0.030
Why?
Analysis of Variance
1
2016
461
0.030
Why?
Influenza A Virus, H5N1 Subtype
1
2014
3
0.030
Why?
Vulnerable Populations
1
2014
25
0.030
Why?
History, 21st Century
1
2014
48
0.030
Why?
History, 20th Century
1
2014
69
0.030
Why?
Drug Discovery
1
2013
30
0.030
Why?
Body Mass Index
1
2017
889
0.030
Why?
Poverty Areas
1
2013
4
0.030
Why?
Agglutination Tests
1
2012
2
0.030
Why?
Technology, Pharmaceutical
1
2012
3
0.030
Why?
Immunization Programs
1
2012
25
0.030
Why?
Communication
1
2014
121
0.030
Why?
Health Policy
1
2012
76
0.030
Why?
Hantavirus
1
2012
1
0.030
Why?
Orientia tsutsugamushi
1
2012
1
0.030
Why?
Rickettsia
1
2012
3
0.030
Why?
Pilot Projects
1
2014
461
0.030
Why?
Medical Records Systems, Computerized
1
2012
21
0.030
Why?
Information Storage and Retrieval
1
2012
25
0.030
Why?
Risk
1
2013
295
0.030
Why?
Specimen Handling
1
2012
32
0.030
Why?
Decision Making
1
2014
189
0.030
Why?
Models, Biological
1
2013
378
0.030
Why?
Feasibility Studies
1
2012
250
0.030
Why?
Acute Disease
1
2012
245
0.030
Why?
Pharyngitis
1
2010
11
0.030
Why?
Cough
1
2010
19
0.020
Why?
RNA, Viral
1
2010
61
0.020
Why?
Time Factors
1
2015
2016
0.020
Why?
Occupational Exposure
1
2013
225
0.020
Why?
Predictive Value of Tests
1
2010
795
0.020
Why?
Brain
1
2012
949
0.020
Why?
Virulence Factors
1
2005
8
0.020
Why?
Virulence
1
2004
19
0.020
Why?
Sex Distribution
1
2005
189
0.020
Why?
Bacterial Proteins
1
2005
75
0.020
Why?
Erythromycin
1
2003
6
0.020
Why?
Multivariate Analysis
1
2005
649
0.010
Why?
Logistic Models
1
2005
734
0.010
Why?
Evidence-Based Medicine
1
2004
208
0.010
Why?
Antibody Formation
1
2002
37
0.010
Why?
Pediatrics
1
2003
134
0.010
Why?
Dose-Response Relationship, Drug
1
2002
650
0.010
Why?
Risk Assessment
1
2005
1317
0.010
Why?
Wierzba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (1)
Explore
_
Similar People (57)
Explore
_
Same Department Expand Description
Explore
_